Pyridine-containing 6-hydrazinonicotinamide derivatives as potential bifunctional chelators for 99mTc-labeling of small biomolecules

Bioconjugate Chemistry

Volumn 15, Issue 4, 2004, Pages 728-737

  Purohit, Ajay ^a   Liu, Shuang ^a,b   Ellars, Charlie E ^a   Casebier, Dave ^a   Haber, Stephen B ^a   Edwards, D Scott ^a  

^a BRISTOL MYERS SQUIBB   (United States)

^b PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; CHELATION; CHLORINE COMPOUNDS; PLANTS (BOTANY); PYRIDINE; SYNTHESIS (CHEMICAL);

BI-FUNCTIONAL; CONFORMATIONAL ISOMERS; DIASTEREOMERS; HIGHER YIELD; LABELINGS; MACROCYCLIC COMPLEX; MACROCYCLICS; PYRIDINE RINGS; RADIOCHEMICAL PURITY; SYNTHESISED;

ISOMERS;

1,6 HEXANEDIAMINE; 6 HYDRAZINONICOTINAMIDE DERIVATIVE; CADAVERINE; LYSINE; MACROCYCLIC COMPOUND; NICOTINAMIDE DERIVATIVE; PYRIDINE DERIVATIVE; STANNOUS CHLORIDE; TECHNETIUM 99M; TRICINE; TRISODIUM TRIPHENYLPHOSPHINE 3,3',3'' TRISULFONATE; UNCLASSIFIED DRUG;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CHELATION; CHEMICAL COMPOSITION; COMPLEX FORMATION; CONFORMATION; DIASTEREOISOMER; ISOMER; ISOTOPE LABELING; PROTEIN ANALYSIS; PROTEIN SYNTHESIS; PROTON NUCLEAR MAGNETIC RESONANCE; ROOM TEMPERATURE;

EID: 3242780154     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc034141c     Document Type: Article

References (36)

1. Edwards, D. S., Liu, S., Ziegler, M. C., Harris, A. R., Crocker, A. C., Heminway, S. J., Barrett, J. A., Bridger, G. J., Abrams, M. J., and Higgins, J. D. (1999) RP463: A stabilized technetium-99m complex of a hydrazino nicotinamide conjugated chemotactic peptide for infection imaging. Bioconjuate Chem. 10, 884-891.
2. m-labeled leukotriene B4 receptor antagonist for scintigraphic detection of infection in rabbits. Nucl. Med. Commun. 21, 1043-1051.
3. 4 receptor antagonist useful for imaging infection. Bioconjugate Chem. 13, 881-886.
4. 99mTc-Labeling of a hydrazinonictotinamide-conjugated vitronectin receptor antagonist. Bioconjugate Chem. 12, 624-629.
5. 99mTc using aminocarboxylates as co-ligands. Bioconjugate Chem. 7, 63-70.
6. 99mTc. Bioconjugate Chem. 8, 146-154.
7. 99mTc-labeling hydrazones of a hydrazinonicotinamide conjugated cyclic peptide. Bioconjuate Chem. 10, 803-807.
8. 2 formulation for DMP444: A new radiopharmaceutical for thrombus imaging. J. Pharm. Sci. 90, 114-123.
9. 99mTc-labeling hydrazones of a hydrazinonicotinamide conjugated cyclic peptide. Bioconjuate Chem. 10, 803-807.
10. 99mTc. Bioconjuate Chem. 9, 583-595.
11. Liu, S., Edwards, D. S., Harris, A. R., Heminway, S. J., and Barrett, J. A. (1999) Technetium complexes of a hydrazinonicotinamide-conjugated cyclic peptide and 2-hydrazinopyridine: Synthesis and characterization. Inorg. Chem. 38, 1326-1335.
12. 99mTc-labeled bioconjugates. Bioconjugate Chem. 11, 113-117.
13. 99mTc- labeling of highly potent small peptides. Bioconjuate Chem. 8, 621-636.
14. 99mTc-labeling of hydrazinonicotinamide modified highly potent small molecules: Problems and solutions. Transition Met. Chem. 22, 425-426.
15. 99mTc-labeled small peptides as diagnostic radiopharmaceuticals. Chem. Rev. 99, 2235-2268.
16. Liu, S., and Edwards, D. S. (2001) New Radiopharmaceuticals for imaging infection and inflammation. Drugs Future 26, 375-382.
17. 99mTc-labeling of small biomolecules. Bioconjugate Chem. 14, 720-727.
18. 99mTc-labeled radiopharmaceuticals. Bioconjugate Chem. 10, 808-814.
19. Abrams, M. J., Juweid, M., tenKate, C. I., Schwartz, D. A., Hauser, M. M., Gaul, F. E., Fuccello, A. J., Rubin, R. H., Strauss, H. W., and Fischman, A. J. (1990) Technetium-99m-human polyclonal IgG radiolabeled via the hydrazino nicotinamide derivative for imaging focal sites of infection in rats. J. Nucl. Med. 31, 2022-2028.
20. 99mTc-protein conjugates. Bioconjugate Chem. 2, 333-336.
21. Ultee, M. E., Bridger, G. J., Abrams, M. J., Longley, C. B., Burton, C. A., Larsen, S., Henson, G. W., Padmanabhan, S., Gaul, F. E., and Schwartz, D. A. (1997) Tumor imaging with technetium-99m-labeled hydrazinonicotinamide-Fab' conjugates. J. Nucl. Med. 38, 133-138.
22. 99mTc-labeling of Fab' monoclonal antibody fragments. Bioconjugate Chem. 7, 255-264.
23. Babich, J. W., Solomon, H., Pike, M. C., Kroon, D., Graham, W., Abrams, M. J., Tompkins, R. G., Rubin, R. H., and Fischman, A. J. (1993) Technetium-99m labeled hydrazino nicotinamide derivatized chemotactic peptide analogues for imaging focal sites of bacterial infection. J. Nucl. Med. 34, 1967-1974.
24. 99mTc-labeled hydrazino nicotinic acid derivatized chemotactic peptides. Nucl. Med. Biol. 22, 25-30.
25. 111In IgG. Nucl. Med. Biol. 22, 643-648.
26. 4N)} core. Inorg. Chim. Acta 309, 123-136
27. 99mTc-labeled peptide-HYNIC conjugates: Effect of lipophilicity and stability on biodistribution. Nucl. Med. Biol. 26, 389-396.
28. 3]Octreotide. Bioconjugate Chem. 10, 431-438.
29. Decristoforo, C., and Mather, S. J. (1999) Technetium-99m somatostatin analogues: Effect of labeling methods and peptide sequence. Eur. J. Nucl. Med. 26, 869-876.
30. 111In-Octreotide. J. Nucl. Med. 41, 1114-119.
31. 3- octreotide. Eur. J. Nucl. Med. 27, 628-637.
32. 111In-labeled octreotide derivatives. Eur. J. Nucl. Med. 27, 1318-1325.
33. 99mTc by the hydrazine nicotinyl derivative. J. Nucl. Med. 40, 192-197.
34. 3 and DTPA) on tumor cell accumulation and mouse biodistribution of technetium-99m labeled antisense DNA. Eur. J. Nucl. Med. 27, 1700-1707.
35. Hnatowich, D. J., Winnard P., Jr., Virzi, F., Santo, T., Smith, C. L., Cantor, C. R., and Rusckowski, M. (1995) Technetium-99m labeling of DNA oligonucleotides. J. Nucl. Med. 36, 2036-2314.
36. 99mTc-HYNIC- folate: A novel receptor-based targeted radiopharmaceutical for tumor imaging. J. Nucl. Med. 40, 1563-1569.